fludarabine has been researched along with brefeldin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carew, JS; Dunner, K; Huang, P; Keating, MJ; Krupnik, YV; McConkey, DJ; Nawrocki, ST | 1 |
Baran-Marszak, F; Bornkamm, GW; Fagard, R; Feuillard, J; Gachard, N; Le Clorennec, C; May, E; Najjar, I; Reminieras, L; Youlyouz-Marfak, I | 1 |
2 other study(ies) available for fludarabine and brefeldin a
Article | Year |
---|---|
Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; B-Lymphocytes; Brefeldin A; Cells, Cultured; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Golgi Apparatus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Proteins; Middle Aged; Multiple Myeloma; Protein Transport; Tumor Necrosis Factor Ligand Superfamily Member 13; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vidarabine | 2006 |
Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Brefeldin A; Cell Line, Tumor; Cisplatin; Dactinomycin; Doxorubicin; Humans; Imatinib Mesylate; Interferons; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-mdm2; Pyrimidines; STAT1 Transcription Factor; Tumor Suppressor Protein p53; Vidarabine | 2008 |